Andrew Sumarsono1, Matthew W Segar2, Luyu Xie3, Folefac Atem3, Sarah E Messiah3, Jenny Kr Francis4, Neil Keshvani2. 1. Department of Medicine, UT Southwestern Medical Center, Dallas TX, USA; Division of Hospital Medicine, Parkland Memorial Hospital, Dallas TX, USA. Electronic address: andrew.sumarsono@utsouthwestern.edu. 2. Department of Medicine, UT Southwestern Medical Center, Dallas TX, USA. 3. University of Texas School of Public Health, Health Science Center at Houston, Dallas TX, USA; Center for Pediatric Population Health, Children's Health System of Texas and University of Texas Health Science Center, Dallas TX, USA. 4. Department of Pediatrics, UT Southwestern Medical Center, Dallas TX, USA; Children's Health, Dallas, TX, USA.
Abstract
INTRODUCTION: Medicaid expansion increased access to care, but longitudinal patterns of contraception use after the Medicaid expansion have not been described. METHODS: We evaluated the effects of Medicaid expansion on the amount and type of contraceptive prescriptions using the Medicaid State Utilization Dataset. RESULTS: Overall long-acting reversible contraception (LARC) use increased in both expansion and non-expansion states. In a difference-in-differences analysis, states that expanded Medicaid had no appreciable increase in per-capita prescription rates of LARC (p = 0.26) or short-acting hormonal contraception (p = 0.09) when compared to nonexpansion states. DISCUSSION: The Medicaid expansion was not associated with a change in per-capita LARC or short-acting hormonal contraception use.
INTRODUCTION: Medicaid expansion increased access to care, but longitudinal patterns of contraception use after the Medicaid expansion have not been described. METHODS: We evaluated the effects of Medicaid expansion on the amount and type of contraceptive prescriptions using the Medicaid State Utilization Dataset. RESULTS: Overall long-acting reversible contraception (LARC) use increased in both expansion and non-expansion states. In a difference-in-differences analysis, states that expanded Medicaid had no appreciable increase in per-capita prescription rates of LARC (p = 0.26) or short-acting hormonal contraception (p = 0.09) when compared to nonexpansion states. DISCUSSION: The Medicaid expansion was not associated with a change in per-capita LARC or short-acting hormonal contraception use.
Authors: Blair G Darney; R Lorie Jacob; Megan Hoopes; Maria I Rodriguez; Brigit Hatch; Miguel Marino; Anna Templeton; Jee Oakley; Erika K Cottrell Journal: JAMA Netw Open Date: 2020-06-01